Diagnosing and treating patients with suspected influenza

American Family Physician

Volumn 72, Issue 9, 2005, Pages

  Ebell, Mark H ^a,b  

^a College of Human Medicine ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; OSELTAMIVIR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIMANTADINE; ZANAMIVIR;

ARTICLE; COST; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE COURSE; HUMAN; IMMUNOFLUORESCENCE; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL INFORMATION; PRIMARY MEDICAL CARE; PROBABILITY; PROPHYLAXIS; RESPIRATORY TRACT INFECTION; SUPERINFECTION;

EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; ORTHOMYXOVIRIDAE; PRACTICE GUIDELINES; PREVALENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VACCINATION;

EID: 27744493515     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-86.
2. Ebell MH, White LL, Casault T. A systematic review of the history and physical examination to diagnose influenza. J Am Board Fam Pract 2004;17:1-5.
3. Rothberg MB, Bellantonio S, Rose DN. Management of influenza in adults older than 65 years of age: costeffeciveness of rapid testing and antiviral therapy. Ann Intern Med 2003;139(pt 1):321-9.
4. Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA 2005;293:987-97.
5. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000;160:3243-7.
6. Centers for Disease Control and Prevention. Flu activity. Reports and surveillance methods in the United States. Accessed online September 14, 2005, at: http://www.cdc.gov/flu/weekly/fluactivity.htm.
7. Hulson TD, Mold JW, Scheid D, Aaron M, Aspy CB, Ballard NL, et al. Diagnosing influenza: the value of clinical clues and laboratory tests. J Fam Pract 2001;50:1051-6.
8. Smith KJ, Roberts MS. Cost-effectiveness of newer treatment strategies for influenza. Am J Med 2002;113:300-7.
9. Jefferson T, Demicheli V, Deeks J, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 1999;(2):CD001265.
10. Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Amantadine and rimantadine for preventing and treating influenza A in adults. Cochrane Database Syst Rev 2004;(3):CD001169.
11. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-33.